As a medium-sized owner-managed company based in Weimar, Senova has specialized in LFA technology and its market launch in recent years. It employs more than 30 people from the areas of research, development, production, sales, logistics, quality management and quality assurance. The major part of their products is based on the widely used lateral flow immunoassay platform.
Since 2011 the company has been certified as a manufacturer for in vitro diagnostics according to ISO 13485. The core business includes the production of rapid test systems and the establishment of new rapid tests for labeling biomarkers, viruses and microorganisms in human, veterinary and environmental samples.